Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

PCR restriction analysis of genome composition and stability of cold-adapted reassortant live influenza vaccines

Identifieur interne : 001D08 ( Main/Exploration ); précédent : 001D07; suivant : 001D09

PCR restriction analysis of genome composition and stability of cold-adapted reassortant live influenza vaccines

Auteurs : Alexander I. Klimov [États-Unis] ; Nancy J. Cox [États-Unis]

Source :

RBID : ISTEX:8311DD707268713DEE5756DC86C1D11DE545146D

English descriptors

Abstract

Abstract: Using cold-adapted master donor strains of influenza virus as a model, an approach was developed that exploits unique nucleotide differences between the donor strains and wild-type influenza viruses for rapidly and simply determining the genome composition and genetic stability of live attenuated vaccine reassortants. The approach is based on PCR amplification of approximately 150–300-nucleotide-long regions of individual RNA segments that include the unique nucleotide positions, followed by restriction nuclease treatment of the DNAs obtained with specific restriction endonucleases. Restriction sites recognized by chosen nucleases either existed or were created during PCR in the genome of one (but not the other) parent strain. The technique requires a minimal amount of infectious virus (approx. 100 μl of allantoic or tissue culture fluid with a haemagglutination titre 1:4–1:8 or less) and allows rapid (within about 10 h) determination of the origin of the RNA segment or the presence of a mutation. The method is beneficial for genome composition analysis of reassortant vaccine strains as well as for investigation of the genetic stability of live attenuated vaccines during replication in vaccinees.

Url:
DOI: 10.1016/0166-0934(94)00133-2


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>PCR restriction analysis of genome composition and stability of cold-adapted reassortant live influenza vaccines</title>
<author>
<name sortKey="Klimov, Alexander I" sort="Klimov, Alexander I" uniqKey="Klimov A" first="Alexander I." last="Klimov">Alexander I. Klimov</name>
</author>
<author>
<name sortKey="Cox, Nancy J" sort="Cox, Nancy J" uniqKey="Cox N" first="Nancy J." last="Cox">Nancy J. Cox</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:8311DD707268713DEE5756DC86C1D11DE545146D</idno>
<date when="1995" year="1995">1995</date>
<idno type="doi">10.1016/0166-0934(94)00133-2</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-CB8QPLCC-8/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000106</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000106</idno>
<idno type="wicri:Area/Istex/Curation">000106</idno>
<idno type="wicri:Area/Istex/Checkpoint">000A83</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A83</idno>
<idno type="wicri:doubleKey">0166-0934:1995:Klimov A:pcr:restriction:analysis</idno>
<idno type="wicri:Area/Main/Merge">001D82</idno>
<idno type="wicri:Area/Main/Curation">001D08</idno>
<idno type="wicri:Area/Main/Exploration">001D08</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">PCR restriction analysis of genome composition and stability of cold-adapted reassortant live influenza vaccines</title>
<author>
<name sortKey="Klimov, Alexander I" sort="Klimov, Alexander I" uniqKey="Klimov A" first="Alexander I." last="Klimov">Alexander I. Klimov</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Influenza Branch, G-16, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333</wicri:regionArea>
<placeName>
<region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Cox, Nancy J" sort="Cox, Nancy J" uniqKey="Cox N" first="Nancy J." last="Cox">Nancy J. Cox</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Influenza Branch, G-16, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333</wicri:regionArea>
<placeName>
<region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Journal of Virological Methods</title>
<title level="j" type="abbrev">VIRMET</title>
<idno type="ISSN">0166-0934</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1995">1995</date>
<biblScope unit="volume">52</biblScope>
<biblScope unit="issue">1–2</biblScope>
<biblScope unit="page" from="41">41</biblScope>
<biblScope unit="page" to="49">49</biblScope>
</imprint>
<idno type="ISSN">0166-0934</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0166-0934</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Attenuated</term>
<term>Attenuated influenza vaccines</term>
<term>Attenuated vaccine reassortants</term>
<term>Attenuated vaccines</term>
<term>Dna</term>
<term>Epidemic virus</term>
<term>Ethidium bromide</term>
<term>Gene</term>
<term>Genes coding</term>
<term>Genetic stability</term>
<term>Genome</term>
<term>Genome composition</term>
<term>Genome composition analysis</term>
<term>High sensitivity</term>
<term>High specificity</term>
<term>Hlnl</term>
<term>Influenza</term>
<term>Influenza vaccines</term>
<term>Influenza virus genome</term>
<term>Influenza viruses</term>
<term>Internal genes</term>
<term>Klimov</term>
<term>Master strain</term>
<term>Master strains</term>
<term>Molecular weight marker</term>
<term>Mutation</term>
<term>Neuraminidase genes</term>
<term>Nucleotide</term>
<term>Nucleotide differences</term>
<term>Other strains</term>
<term>Other viruses</term>
<term>Primer</term>
<term>Reassortant</term>
<term>Reassortant vaccine strains</term>
<term>Reassortant viruses</term>
<term>Reassortants</term>
<term>Replication</term>
<term>Restriction</term>
<term>Restriction analysis</term>
<term>Restriction enzyme</term>
<term>Restriction enzymes</term>
<term>Restriction sites</term>
<term>Sequence analysis</term>
<term>Sequence changes</term>
<term>Tissue culture fluid</term>
<term>Unique nucleotide positions</term>
<term>Vaccine</term>
<term>Vaccine reassortant</term>
<term>Vaccine reassortants</term>
<term>Vaccinee</term>
<term>Virological methods</term>
<term>Virus</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: Using cold-adapted master donor strains of influenza virus as a model, an approach was developed that exploits unique nucleotide differences between the donor strains and wild-type influenza viruses for rapidly and simply determining the genome composition and genetic stability of live attenuated vaccine reassortants. The approach is based on PCR amplification of approximately 150–300-nucleotide-long regions of individual RNA segments that include the unique nucleotide positions, followed by restriction nuclease treatment of the DNAs obtained with specific restriction endonucleases. Restriction sites recognized by chosen nucleases either existed or were created during PCR in the genome of one (but not the other) parent strain. The technique requires a minimal amount of infectious virus (approx. 100 μl of allantoic or tissue culture fluid with a haemagglutination titre 1:4–1:8 or less) and allows rapid (within about 10 h) determination of the origin of the RNA segment or the presence of a mutation. The method is beneficial for genome composition analysis of reassortant vaccine strains as well as for investigation of the genetic stability of live attenuated vaccines during replication in vaccinees.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Géorgie (États-Unis)</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Géorgie (États-Unis)">
<name sortKey="Klimov, Alexander I" sort="Klimov, Alexander I" uniqKey="Klimov A" first="Alexander I." last="Klimov">Alexander I. Klimov</name>
</region>
<name sortKey="Cox, Nancy J" sort="Cox, Nancy J" uniqKey="Cox N" first="Nancy J." last="Cox">Nancy J. Cox</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D08 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001D08 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:8311DD707268713DEE5756DC86C1D11DE545146D
   |texte=   PCR restriction analysis of genome composition and stability of cold-adapted reassortant live influenza vaccines
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021